Search

The human immunodeficiency virus-1 (HIV-1) envelope protein gp120 is the major contributor to the pathogenesis of HIV-associated neurocognitive disorder (HAND). Neuroinflammation plays a pivotal role in gp120-induced neuropathology, but how gp120 triggers neuroinflammatory processes and subsequent neuronal death remains unknown. Here, we provide evidence that NLRP3 is required for gp120-induced neuroinflammation and neuropathy. Our results showed that gp120-induced NLRP3-dependent pyroptosis and IL-1β production in microglia. Inhibition of microglial NLRP3 inflammasome activation alleviated gp120-mediated neuroinflammatory factor release and neuronal injury. Importantly, we showed that chronic administration of MCC950, a novel selective NLRP3 inhibitor, to gp120 transgenic mice not only attenuated neuroinflammation and neuronal death but also promoted neuronal regeneration and restored the impaired neurocognitive function. In conclusion, our data revealed that the NLRP3 inflammasome is important for gp120-induced neuroinflammation and neuropathology and suggest that NLRP3 is a potential novel target for the treatment of HAND.

Knowledge of blood triacylglycerol (TAG) species is essential to clarify the physiological functions of individual TAG molecules and also to develop potential biomarkers for related diseases. Commonly, lipid samples prepared by organic liquid-liquid extraction contain complex components, thus cannot be directly characterized by mass spectrometry (MS) and often require an additional purification step. Here, we described a laser desorption ionization - mass spectrometry (LDI-MS) method that utilized aggregated graphene oxide (AGO) as both lipid extractant and MS matrix (AGOLDI-MS), to characterize and quantify plasma TAG species without the use of harmful solvent or complex separation step. We first designed and synthesized the AGO material with a multi-layered sheet structure, which could efficiently break up the structure of lipoproteins, and extract plasma TAGs as solid-phase extraction material. Furthermore, in AGOLDI-MS procedure, the AGO could directly act as matrix and selectively produce the MS signals of TAGs without the interferences of phospholipids, which was hardly achieved by using the routine LDI-MS method based on liquid-liquid extraction and small molecular matrix. We confirmed the suitability of AGOLDI-MS as characterization and quantitative tool for TAG species through studying the analysis performances in TAG standards and real plasma samples. To establish potential utility of our method, we characterized 42 human plasmas from healthy and hyperlipemic donators, indicating that the AGOLDI-MS could not only generate comparable quantitative results of total TAGs to current clinical technology, but also monitor the changes of TAG species between different sample groups. This approach could further characterize the compositions of the fatty acid moieties in even low abundant TAGs by the assistance of tandem MS-MS. This concise, specific, and high-throughput approach will facilitate the rapid and precise characterizations of plasma TAGs, and make the MS approach for TAGs more adaptable for clinical uses., (Copyright © 2018 Elsevier B.V. All rights reserved.)

The process for production of trehalose using trehalose synthase (TreS) to convert maltose into trehalose in one step is highly desirable in the industry. Nonetheless, the studies on industrial-scale production of trehalose by recombinant TreS in Escherichia coli are still scarce. In this study, a TreS from Pseudomonas putida ATCC47054 was expressed in E. coli BL21(DE3) via plasmids pET15b and pET22b. pET15b-treS showed better plasmid stability and TreS expression, which revealed that the highest activity, 39866±1420U/(g dry cell weight) at the final lactose concentration of 4g/L for 7h at 27°C in a 5-L fermentor at pH 8.0. The use of 30% (w/v) high-maltose syrup as a substrate can extend the temperature tolerance of TreS to 60°C. More than 64% of maltose can be converted into trehalose by adding 200U of TreS per gram of maltose at 50°C for 24h. The total sugar content of the trehalose syrup reached 95.0%±1.0% (w/w) after separation. The recovery rate of trehalose dehydrate reached 57.0%±2.0% after slow cooling, and the purity was 99.0±0.2%. Our study revealed a safe and reliable process of trehalose production by recombinant TreS., (Copyright © 2017 Elsevier Inc. All rights reserved.)

Heterogeneous catalytic activation is important for potential application of new sulfate-radical-based advanced oxidation process using sulfite as source of sulfate radical. We report herein a heterogeneous system for sulfite activation by CoFe 2 O 4 nanocatalyst for metoprolol removal. Factors that influence metoprolol removal were investigated, including pH and initial concentrations of components. The CoFe 2 O 4 nanocatalyst was characterized by X-ray diffractometry (XRD) and transmission electron microscopy (TEM), and the catalytic stability was tested by consecutive runs. Radicals generated in the CoFe 2 O 4 S(IV)O 2 system were identified through radical quenching experiments and by electron spin resonance (ESR). The catalytic mechanism was elucidated further by X-ray photoelectron spectroscopy (XPS). The catalytic process was dependent on initial pH, and more than 80% of the metoprolol can be removed at pH 10.0 following the Langmubir-Hinshelwood equation. The generation of Co-OH complexes on the CoFe 2 O 4 surface was crucial for sulfite activation. SO 4 - was verified to be the main oxidative species responsible for metoprolol degradation. Other organic pollutants, such as sulfanilamide, sulfasalazine, 2-nitroaniline, sulfapyridine, aniline, azo dye X-3B and 4-chloroaniline, could also be removed in this CoFe 2 O 4 S(IV)O 2 system. The results suggest that the CoFe 2 O 4 S(IV)O 2 system has good application prospects in alkaline organic wastewater treatment., (Copyright © 2016 Elsevier B.V. All rights reserved.)